Faculty profile
Ruth Marrie
Back to facultyThis profile is built from public research funding records (CIHR, NSERC and SSHRC). We have not imported them from a University of British Columbia directory, so their publications, courses and email address may be missing. Find their university profile.
Research
Latest funding
- $393,974
Early Warning Signs of Immune-Mediated Chronic Diseases: A Comparative Study of the Prodromal Phase in Multiple Sclerosis (MS) and Other Immune-Mediated Inflammatory Disorders (ProMS-ID)
CIHR · 2025 · Co-investigator
- $153,000
Developing an Epidemiological Tool for Early Detection: A Risk Prediction Algorithm for Prodromal Multiple Sclerosis
CIHR · 2024 · Co-investigator
- $470,475
Predictive modeling in multiple sclerosis: using real world data to inform practice, policy, and research
CIHR · 2021 · Co-investigator
Early Warning Signs of Immune-Mediated Chronic Diseases: A Comparative Study of the Prodromal Phase in Multiple Sclerosis (MS) and Other Immune-Mediated Inflammatory Disorders (ProMS-ID)
Principal investigators: Tremlett, Helen L
Keywords: Disease Prevention; Early Detection; Epidemiology; Health Administrative Data; Immune-Mediated Inflammatory Disease; Multiple Sclerosis; Population-Based; Prodrome
Developing an Epidemiological Tool for Early Detection: A Risk Prediction Algorithm for Prodromal Multiple Sclerosis
Principal investigators: Karim, Mohammad E
Keywords: Comorbidity; Early Detection; Health Administrative Data; Linked Clinical Administrative Data; Machine Learning; Multiple Sclerosis; Prediction; Predictive Modelling; Prodrome; Risk Score
Predictive modeling in multiple sclerosis: using real world data to inform practice, policy, and research
Principal investigators: Cragg, Jacquelyn J; Lynd, Larry D
Keywords: Data Linkage; Disease Progression; Multiple Sclerosis; Predictive Disease Modeling
Tumor necrosis factor inhibitors (TNFi) and Risk of Multiple Sclerosis
Principal investigators: Etminan, Mahyar; Avina-Zubieta, Juan A; Tremlett, Helen L
Keywords: Case-Control Study; Drug Safety; Epidemiology; Inflammatory Bowel Disease; Large Administrative Databases; Multiple Sclerosis; Patient Safety; Rheumatic Diseases; Tumor Necrosis Factor Inhibitors
Disease-modifying Drug Safety and Effectiveness in Multiple Sclerosis [DRUMS]
Principal investigators: Tremlett, Helen L
Keywords: Disability; Disease Prevention; Drug Effectiveness; Drug Repurposing; Health Administrative Data; Mortality; Multiple Sclerosis; Pharmacoepidemiology; Pharmacovigilance; Population-Based Cohorts
Prescription Drug Safety and Effectiveness in Multiple Sclerosis [DRUMS]: a population-based, multi-province platform for comprehensive pharmacovigilance
Principal investigators: Tremlett, Helen L; Evans, Charity D; Fisk, John D; Marrie, Ruth Ann; Patten, Scott B
Keywords: Chronic Disease; Disability; Disease Modifying Drugs; Drug Effectiveness; Drug Safety; Health Administrative Data; Multiple Sclerosis; Pharmacovigilance; Population-Based; Post-Marketing, Real World
The Children of Multiple Sclerosis: Impact of chronic disease in parents on early childhood development
Principal investigators: Tremlett, Helen L; Hertzman, Clyde
Keywords: Child Development; Data Linkage; Epidemiology; Health Administrative Data; Health Outcomes; Multiple Sclerosis
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.